查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462650

到 2030 年腦積水引流裝置市場預測：按產品類型、分流器類型、年齡層、最終用戶和地區進行的全球分析

Hydrocephalus Shunt Market Forecasts to 2030 - Global Analysis By Product, Shunt Type, Age Group, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球腦積水引流裝置市場規模為 3.222 億美元，預計在預測期內將以 6.1% 的年複合成長率成長，並在 2030 年達到 4.876 億美元。

臨床上用於治療涉及腦脊髓液過多的精神疾病的裝置稱為腦積水儲存腦積水引流裝置。顱內壓因子增大是顱骨的這種狀況的結果。這些設備收集體液有助於減輕大腦的壓力。分流器是一種透過手術植入的裝置，旨在將多餘的腦脊髓液從大腦轉移到身體的另一個位置，通常是腹腔，在那裡它可以被自然吸收。

根據美國生物化學與分子生物學學會2021年3月發表的論文，美國每年約有280萬人遭受創傷性腦損傷（TBI），其中約28萬人需要住院治療。

分流技術的進步

分流技術的進步包括可程式設計和可調節分流系統的開發、使用新材料來提高生物相容性和壽命，以及微創手術技術的引入。可程式設計分流器可在放置分流器後調整流量設置，從而更靈活地管理患者的水腦症。此外，將創新材料納入分流器設計可提高分流器性能並降低感染和閉塞等併發症的風險。

成本限制

水腦症的特徵是腦脊髓液在大腦中儲存，通常需要使用分流裝置進行手術干涉以緩解症狀。與分流創建相關的高昂成本，包括手術、裝置植入和持續維護，給患者和醫療保健提供者帶來了經濟負擔。但有限的保險覆蓋範圍，特別是在醫療保健基礎設施不足的地區，可能會使問題變得更加複雜，並延遲或拒絕獲得基本治療。

微創手術需求不斷成長

與傳統開顱手術相比，微創手術具有多種優勢，包括減少創傷、恢復時間更快、住院時間更短以及感染和出血等併發症的風險最小化。對於水腦症，通常需要植入分流器來管理過量的腦脊髓液儲存，微創方法提供了比傳統方法侵入性更小的替代方案。這些手術通常使用較小的切口、專用器械，有時還會使用內視鏡引導，以幫助外科醫生更精確地放置分流器並最大限度地減少對周圍組織的損害。

獲得治療的機會不足

水腦症指腦脊髓液在大腦中儲存，通常需要透過分流器進行手術治療以緩解症狀。然而，衛生基礎設施的差異，特別是在服務欠缺地區和開發中國家，限制了及時診斷、治療和後續護理的機會。有限的醫療設施、訓練有素的醫務人員和財政限制等挑戰加劇了這項挑戰。因此，許多水腦症患者沒有接受必要的分流手術或延遲手術，導致發病率和死亡率增加。

COVID-19 的影響：

隨著世界各地的醫療保健系統投入資源對抗這場流行病，包括水腦症手術在內的擇期手術被推遲或取消，以優先考慮 COVID-19 患者並最大限度地降低感染風險。這導致分流器植入和置換的減少，導致市場低迷。此外，對非必要醫療程序的限制以及患者因擔心感染病毒而不願去醫院的情況進一步減少了需求。

預計在預測期內水腦症導管部分將是最大的

在預測期內，水腦症導管細分市場是市場上最大的細分市場，因為導管設計和材料的進步提高了分流系統的有效性和壽命，改善了患者的治療效果並減少了翻修手術的需求。先天性水腦症和正常水腦症等疾病的盛行率不斷增加，刺激了對有效治療方案的需求，導致世界腦積水引流裝置手術的增加。此外，導管製造的創新促進了微創技術的發展，使分流器置入手術更安全、更容易被病人接受。

腦室腹腔分流部分預計在預測期內年複合成長率最高

腦室分流部分預計將在預測期內實現盈利成長，因為它在治療水腦症（一種以腦室內腦脊髓液儲存為特徵的疾病）方面有效且廣泛採用。 VP 分流器提供了一種微創解決方案，將多餘的液體從腦室轉移到腹腔，然後自然吸收到體內。這種方法不僅可以緩解顱內壓，還有助於緩解與水腦症，如頭痛、噁心和認知障礙。

佔比最高的地區

由於神經系統疾病盛行率上升、患者對微創治療方法的偏好、醫療成本上升以及導致分流技術進步的研發力度不斷加大等原因，北美的腦積水引流裝置市場正在成長，這是成長最快且成長最快的市場。 佔估計期間銷售額的最大佔有率。例如，醫療保險和醫療補助服務中心 (CMS) 預測 2022 年美國醫療保健支出將為 7.5%。預計 2023 年支出將首次超過 1 兆美元。

年複合成長率最高的地區：

由於該地區醫療基礎設施的改善、手術數量的增加以及與政府擴大醫療設備組合的協議，預計亞太市場在預測期內將實現盈利成長。例如，2022年3月，日本和印度總理核准了一項五年財政計畫和420億美元的投資，以支持醫療設備製造合資企業。由於醫療成本不斷上升，印度醫療保健系統的服務組合正在從護理轉向疾病管理的預防保健。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次研究資料
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球腦積水引流裝置市場：依產品

  • 水腦症導管
    • 抗菌導管
    • 標準導管
  • 水腦症瓣膜
    • 定壓閥
    • 可調壓力閥
  • 其他產品

第6章全球腦積水引流裝置市場：依分流器類型

  • 腦室胸膜分流術
  • 腰部腹腔分流術
  • 心房分流術
  • 腦室腹腔分流術
  • 其他分流器類型

第7章全球腦積水引流裝置市場：依年齡族群

  • 成人
  • 兒童

第8章全球腦積水引流裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 其他最終用戶

第9章全球腦積水引流裝置市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Aesculap, Inc
  • B. Braun Melsungen AG
  • Christoph Miethke GmbH & Co. KG
  • G. Surgiwear Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic
  • Natus Medical Incorporated
  • Sophysa
  • Spiegelberg GmbH & Co. KG
Product Code: SMRC25701

According to Stratistics MRC, the Global Hydrocephalus Shunt Market is accounted for $322.2 million in 2023 and is expected to reach $487.6 million by 2030 growing at a CAGR of 6.1% during the forecast period. An apparatus used in clinical practice to help treat a mental illness involving excessive cerebrospinal fluid collection is referred to as a hydrocephalus shunt. An expanded intracranial pressing factor is the result of this condition in the skull. The fluid collection caused by these devices helps reduce stress in the brain. Shunts are surgically implanted devices designed to divert excess cerebrospinal fluid from the brain to another part of the body, typically the abdominal cavity, where it can be absorbed naturally.

According to an article published by the American Society for Biochemistry and Molecular Biology in March 2021, in the United States, about 2.8 million people sustain a traumatic brain injury (TBI) every year, with some 280,000 resulting in hospitalizations.

Market Dynamics:

Driver:

Advancements in shunt technology

The advancements encompass a wide range of improvements, including the development of programmable and adjustable shunt systems, utilization of novel materials for improved biocompatibility and longevity, and the introduction of minimally invasive surgical techniques. Programmable shunts offer the ability to adjust flow settings post-implantation, providing greater flexibility in managing patients' hydrocephalus symptoms. Additionally, the integration of innovative materials into shunt designs enhances their performance and reduces the risk of complications such as infection and blockage.

Restraint:

Cost constraints

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid in the brain, often requires surgical intervention with shunt devices to alleviate symptoms. The high cost associated with shunt placement, including surgery, device implantation, and ongoing maintenance, poses financial burdens for patients and healthcare providers alike. However, limited insurance coverage, particularly in regions with inadequate healthcare infrastructure, further exacerbates the issue, potentially delaying or denying access to essential treatment.

Opportunity:

Growing demand for minimally invasive surgical procedures

Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced trauma, faster recovery times, shorter hospital stays, and minimized risk of complications such as infection and bleeding. In the context of hydrocephalus, where patients often require shunt implantation to manage excess cerebrospinal fluid buildup, minimally invasive approaches provide a less invasive alternative to traditional methods. These techniques typically involve smaller incisions, specialized tools, and sometimes even endoscopic guidance, allowing surgeons to place shunts with greater precision and minimal disruption to surrounding tissues.

Threat:

Inadequate access to care

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid within the brain, often requires surgical intervention with shunts to alleviate symptoms. However, disparities in healthcare infrastructure, particularly in underserved regions and developing countries, limit access to timely diagnosis, treatment, and follow-up care. Factors such as limited healthcare facilities, insufficient trained medical personnel, and financial constraints contribute to this challenge. Consequently, many individuals with hydrocephalus lack access to essential shunt surgeries or experience delays in receiving them, leading to increased morbidity and mortality rates.

Covid-19 Impact:

As healthcare systems worldwide redirected resources to combat the pandemic, elective surgeries, including those for hydrocephalus, were postponed or canceled to prioritize COVID-19 patients and minimize transmission risks. This led to a decrease in shunt implantations and replacements, resulting in a downturn in the market. Moreover, restrictions on non-essential medical procedures, coupled with patients' reluctance to visit hospitals due to fear of contracting the virus, further dampened demand.

The Hydrocephalus Catheter segment is expected to be the largest during the forecast period

Hydrocephalus Catheter segment commanded the largest share of the market over the projection period as advancements in catheter design and materials have improved the efficacy and longevity of shunt systems, enhancing patient outcomes and reducing the need for revision surgeries. The increasing prevalence of conditions such as congenital hydrocephalus and normal pressure hydrocephalus is fueling demand for effective treatment options, leading to a rising number of hydrocephalus shunt procedures worldwide. Moreover, technological innovations in catheter manufacturing have allowed for the development of minimally invasive techniques, making shunt placement procedures safer and more accessible to patients.

The Ventriculoperitoneal Shunts segment is expected to have the highest CAGR during the forecast period

Ventriculoperitoneal Shunts segment is poised to witness profitable growth during the overcast period due to its effectiveness and widespread adoption in treating hydrocephalus-a condition characterized by the accumulation of cerebrospinal fluid in the brain's ventricles. VP shunts offer a minimally invasive solution by diverting excess fluid from the brain's ventricles to the peritoneal cavity, where it can be naturally absorbed by the body. This approach not only relieves intracranial pressure but also helps alleviate symptoms associated with hydrocephalus, such as headaches, nausea, and cognitive impairment.

Region with largest share:

Because of the rising prevalence of neurological disorders, patients' preference for less invasive procedures, rising healthcare costs, and improved research and development efforts leading to advancements in shunt technology, the hydrocephalus shunts market has grown most rapidly in North America, accounting for the largest revenue share over the extrapolated period. The Centers for Medicare & Medicaid Services (CMS), for instance, projected that in 2022, health spending in the United States would be 7.5%. The first time that spending is expected to surpass $1 trillion USD is in 2023.

Region with highest CAGR:

Because of the region's improved healthcare infrastructure, rising number of surgeries, and government agreements to expand the medical device portfolio, the Asia Pacific market is expected to grow profitably over the projected period. For instance, the prime ministers of Japan and India approved a five-year financial plan and an investment of USD 42 billion in March 2022 to support a joint venture in medical equipment production. Due to rising healthcare costs, India's healthcare system is witnessing a shift in its service portfolio from nursing care to preventative care for disease control.

Key players in the market

Some of the key players in Hydrocephalus Shunt market include Aesculap, Inc, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd, Integra LifeSciences, Johnson & Johnson, Medtronic, Natus Medical Incorporated, Sophysa and Spiegelberg GmbH & Co. KG.

Key Developments:

In November 2023, for young patients suffering from hydrocephalus-a neurological disorder that results in an accumulation of cerebral fluid in the interior spaces of the brain which often requires repeated hospital stays-surgeons at Intermountain Primary Children's Hospital successfully placed a novel brain shunt accessory, becoming the first hospital in the U.S. to accomplish the same.

In October 2023, through its Blueprint MedTech initiative, the NINDS (National Institute of Neurological Disorders and Stroke) of the National Institutes of Health (NIH) awarded Rhaeos, Inc. a USD 1.5 million grant. With this award, the company will continue to develop its FDA-designated breakthrough medical technology, which aims to revolutionize the treatment of hydrocephalus, a brain disorder that affects more than a million people in the U.S.

In July 2023, Cerevasc Inc. partnered with Lianmedical Co. Ltd. to introduce its medical devices for neurological diseases in Asia. Lianmedical marketed Cerevasc's eshunt system and related products in mainland China, Hong Kong, Taiwan, and Macau, facilitating percutaneous transvenous-transdural access to the central nervous system.

Products Covered:

  • Hydrocephalus Catheter
  • Hydrocephalus Valves
  • Other Products

Shunt Types Covered:

  • Ventriculopleural Shunts
  • Lumboperitoneal Shunts
  • Ventriculoatrial Shunts
  • Ventriculoperitoneal Shunts
  • Other Shunt Types

Age Groups Covered:

  • Adult
  • Pediatric

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hydrocephalus Shunt Market, By Product

  • 5.1 Introduction
  • 5.2 Hydrocephalus Catheter
    • 5.2.1 Antimicrobial Catheters
    • 5.2.2 Standard Catheters
  • 5.3 Hydrocephalus Valves
    • 5.3.1 Fix Pressure Valves
    • 5.3.2 Adjustable Pressure Valves
  • 5.4 Other Products

6 Global Hydrocephalus Shunt Market, By Shunt Type

  • 6.1 Introduction
  • 6.2 Ventriculopleural Shunts
  • 6.3 Lumboperitoneal Shunts
  • 6.4 Ventriculoatrial Shunts
  • 6.5 Ventriculoperitoneal Shunts
  • 6.6 Other Shunt Types

7 Global Hydrocephalus Shunt Market, By Age Group

  • 7.1 Introduction
  • 7.2 Adult
  • 7.3 Pediatric

8 Global Hydrocephalus Shunt Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Hydrocephalus Shunt Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Aesculap, Inc
  • 11.2 B. Braun Melsungen AG
  • 11.3 Christoph Miethke GmbH & Co. KG
  • 11.4 G. Surgiwear Ltd
  • 11.5 Integra LifeSciences
  • 11.6 Johnson & Johnson
  • 11.7 Medtronic
  • 11.8 Natus Medical Incorporated
  • 11.9 Sophysa
  • 11.10 Spiegelberg GmbH & Co. KG

List of Tables

  • Table 1 Global Hydrocephalus Shunt Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 4 Global Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 5 Global Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 6 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 7 Global Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 8 Global Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 9 Global Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 11 Global Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 12 Global Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 13 Global Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 14 Global Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 15 Global Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 16 Global Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 17 Global Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 18 Global Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 19 Global Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 21 Global Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 22 Global Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 25 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 26 North America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 27 North America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 28 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 29 North America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 30 North America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 31 North America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 32 North America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 33 North America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 34 North America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 35 North America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 36 North America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 37 North America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 38 North America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 39 North America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 40 North America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 41 North America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 43 North America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 44 North America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 47 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 48 Europe Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 49 Europe Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 50 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 51 Europe Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 52 Europe Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 53 Europe Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 54 Europe Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 55 Europe Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 56 Europe Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 57 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 58 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 59 Europe Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 60 Europe Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 61 Europe Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 62 Europe Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 63 Europe Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Europe Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 65 Europe Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 66 Europe Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 69 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 70 Asia Pacific Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 71 Asia Pacific Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 72 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 73 Asia Pacific Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 74 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 75 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 76 Asia Pacific Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 77 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 78 Asia Pacific Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 79 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 80 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 81 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 82 Asia Pacific Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 83 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 84 Asia Pacific Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 85 Asia Pacific Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 87 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 88 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 91 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 92 South America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 93 South America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 94 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 95 South America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 96 South America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 97 South America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 98 South America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 99 South America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 100 South America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 101 South America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 102 South America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 103 South America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 104 South America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 105 South America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 106 South America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 107 South America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 108 South America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 109 South America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 110 South America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 111 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
  • Table 113 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
  • Table 114 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
  • Table 115 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
  • Table 116 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
  • Table 117 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
  • Table 118 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
  • Table 119 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 120 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
  • Table 121 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
  • Table 122 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
  • Table 123 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
  • Table 124 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
  • Table 125 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
  • Table 126 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 127 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
  • Table 128 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 129 Middle East & Africa Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
  • Table 130 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 131 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 132 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)